RALEIGH, N.C.--(BUSINESS WIRE)--BioDelivery Sciences International, Inc. (NASDAQ: BDSI) today announced that manufacturing of ONSOLIS has resumed as planned after a brief, voluntary shut down at Aveva Drug Delivery Systems, the contract manufacturer for ONSOLIS.
